SE9902918D0 - Methods for identification of compounds stimulating insulin secretion - Google Patents

Methods for identification of compounds stimulating insulin secretion

Info

Publication number
SE9902918D0
SE9902918D0 SE9902918A SE9902918A SE9902918D0 SE 9902918 D0 SE9902918 D0 SE 9902918D0 SE 9902918 A SE9902918 A SE 9902918A SE 9902918 A SE9902918 A SE 9902918A SE 9902918 D0 SE9902918 D0 SE 9902918D0
Authority
SE
Sweden
Prior art keywords
identification
compounds
methods
insulin secretion
tubulin
Prior art date
Application number
SE9902918A
Other languages
English (en)
Inventor
Per-Olof Berggren
Thomas Lundbaeck
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9902918A priority Critical patent/SE9902918D0/sv
Publication of SE9902918D0 publication Critical patent/SE9902918D0/sv
Priority to JP2001517172A priority patent/JP2003507365A/ja
Priority to PCT/SE2000/001563 priority patent/WO2001013121A1/en
Priority to CA002380983A priority patent/CA2380983A1/en
Priority to EP00953612A priority patent/EP1200835A1/en
Priority to NZ516788A priority patent/NZ516788A/en
Priority to AU66032/00A priority patent/AU6603200A/en
Priority to US09/637,134 priority patent/US6586188B1/en
Priority to NO20020576A priority patent/NO20020576D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9902918A 1999-08-13 1999-08-13 Methods for identification of compounds stimulating insulin secretion SE9902918D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9902918A SE9902918D0 (sv) 1999-08-13 1999-08-13 Methods for identification of compounds stimulating insulin secretion
JP2001517172A JP2003507365A (ja) 1999-08-13 2000-08-10 インシュリン分泌を促進する化合物の同定法
PCT/SE2000/001563 WO2001013121A1 (en) 1999-08-13 2000-08-10 Methods for identification of compounds stimulating insulin secretion
CA002380983A CA2380983A1 (en) 1999-08-13 2000-08-10 Methods for identification of compounds stimulating insulin secretion
EP00953612A EP1200835A1 (en) 1999-08-13 2000-08-10 Methods for identification of compounds stimulating insulin secretion
NZ516788A NZ516788A (en) 1999-08-13 2000-08-10 Methods for identification of compounds stimulating insulin secretion
AU66032/00A AU6603200A (en) 1999-08-13 2000-08-10 Methods for identification of compounds stimulating insulin secretion
US09/637,134 US6586188B1 (en) 1999-08-13 2000-08-11 Method for identification of compounds that bind to β-tubulin and stimulate insulin secretion
NO20020576A NO20020576D0 (no) 1999-08-13 2002-02-05 Fremgangsmåter for identifisering av forbindelser som stimulerer insulinsekresjon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9902918A SE9902918D0 (sv) 1999-08-13 1999-08-13 Methods for identification of compounds stimulating insulin secretion

Publications (1)

Publication Number Publication Date
SE9902918D0 true SE9902918D0 (sv) 1999-08-13

Family

ID=20416679

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9902918A SE9902918D0 (sv) 1999-08-13 1999-08-13 Methods for identification of compounds stimulating insulin secretion

Country Status (8)

Country Link
EP (1) EP1200835A1 (sv)
JP (1) JP2003507365A (sv)
AU (1) AU6603200A (sv)
CA (1) CA2380983A1 (sv)
NO (1) NO20020576D0 (sv)
NZ (1) NZ516788A (sv)
SE (1) SE9902918D0 (sv)
WO (1) WO2001013121A1 (sv)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260275A (en) * 1990-08-14 1993-11-09 Amylin Pharmaceuticals, Inc. Hypoglycemics
AU3953595A (en) * 1994-10-07 1996-05-02 Merck & Co., Inc. Process for assessing tubulin protein polymerization
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment

Also Published As

Publication number Publication date
JP2003507365A (ja) 2003-02-25
WO2001013121A1 (en) 2001-02-22
AU6603200A (en) 2001-03-13
NO20020576L (no) 2002-02-05
EP1200835A1 (en) 2002-05-02
NZ516788A (en) 2003-07-25
NO20020576D0 (no) 2002-02-05
CA2380983A1 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
EP1140840A4 (en) DIPHENYLUREA WITH SUBSTITUENTS -G (V) -CARBOXYARYLES, INHIBITORS OF RAF KINASE
ATE125867T1 (de) Fibronektinbindungsprotein und dessen herstellung.
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
HK1155944A1 (en) W-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
DE69829412D1 (de) Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen
DE69823046D1 (de) Praktische in vitro sialylierung von rekombinanten glykpproteinen
HK1022701A1 (en) Exendin analogues, processes for their preparationand medicaments containing them exendin.
WO2003008444A3 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
WO2003101401A3 (en) Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
TR199700610A3 (tr) Düsük molekül agirlikli çözünür, tümör nekroz faktörü tip-I ve tip-II proteinleri.
DE60125734D1 (en) Neue aryl fructose-1,6-bisphosphatase inhibitoren
ATE313802T1 (de) Bestimmung von adrenomedullin-bindenden proteinen
ATE226634T1 (de) Fibronektin bindendes protein
FR2827866B1 (fr) Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations
ATE223481T1 (de) Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator
ATE120494T1 (de) Fibronectinbindungsprotein und dessen herstellung.
ATE139541T1 (de) Kollagen-bindendes protein sowie dessen herstellung
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
SE9902918D0 (sv) Methods for identification of compounds stimulating insulin secretion
DE60036555D1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
WO2000032629A3 (en) Antiviral peptides
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
DK0925333T3 (da) Froststabilisering af vandige overtræksmidler med frostbeskyttelsesproteiner